132 related articles for article (PubMed ID: 31200637)
1. ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.
Liu X; Lin L; Li Q; Ni Y; Zhang C; Qin S; Wei J
BMC Mol Cell Biol; 2019 Jun; 20(1):14. PubMed ID: 31200637
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
4. Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.
Correa MV; Nolly MB; Caldiz CI; de Cingolani GE; Cingolani HE; Ennis IL
Pflugers Arch; 2014 Sep; 466(9):1819-30. PubMed ID: 24327206
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
6. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
Tanner MA; Thomas TP; Grisanti LA
J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246
[TBL] [Abstract][Full Text] [Related]
7. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
[TBL] [Abstract][Full Text] [Related]
8. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling.
Hayata N; Fujio Y; Yamamoto Y; Iwakura T; Obana M; Takai M; Mohri T; Nonen S; Maeda M; Azuma J
Biochem Biophys Res Commun; 2008 May; 370(2):274-8. PubMed ID: 18375200
[TBL] [Abstract][Full Text] [Related]
11. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
15. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH
Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107
[TBL] [Abstract][Full Text] [Related]
16. Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.
Mao Q; Wu S; Peng C; Peng B; Luo X; Huang L; Zhang H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278478
[TBL] [Abstract][Full Text] [Related]
17. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
18. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W
Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
